Form 4 for XAIR Beyond Air, Inc.

Accepted 2023-03-28 00:00:00 ET · period of report 2023-03-27 · accession 0001493152-23-009295 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-03-28	2023-03-27	XAIR	Myers Jeff Lynn	Chief Medical Off	A - Grant	$0.00	+50.0K	50.0K	New	$0
D	2023-03-28	2023-03-27	XAIR	Myers Jeff Lynn	Chief Medical Off	A - Grant	$0.00	+50.0K	50.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-03-27	A	A	50,000	$0.00	50,000	D	—	—	(F1) Represents restricted stock units ("RSUs") granted on March 27, 2023 to acquire 50,000 shares of common stock of Beyond Air, Inc. (the "Issuer"). The RSUs will vest as to 20% of the shares of common stock underlying the RSUs on December 15, 2023, with the remainder vesting in equal annual installments on December 15 of each of the four ensuing years thereafter until vested in full, in each case subject to the reporting person's continued service with the Issuer. Each RSU represents the right to receive one share of common stock of the Issuer.
2	Derivative	Stock Option (right to buy)	2023-03-27	A	A	50,000	$0.00	50,000	D	$6.14 · — to 2033-03-26	50,000 Common Stock	(F2) The option will vest as to 25% of the shares of common stock underlying the option on March 27, 2024, with the remainder vesting in equal annual installments on March 27 of each of the three ensuing years thereafter until vested in full, in each case subject to the reporting person's continued service with the Issuer.